Ilyang Pharmaceutical Co.,Ltd Cash Flow Reinvestment Rate

Latest as of March 2026: 0.10x

Ilyang Pharmaceutical Co.,Ltd cash flow reinvestment rate. Ilyang Pharmaceutical Co.,Ltd (007575) has a Cash Flow Reinvestment Rate of 0.10x as of March 2026, reinvesting ₩2.74 Billion (capex ₩1.74 Billion plus investments ₩1.00 Billion) from operating cash flow of ₩26.51 Billion. Explore Ilyang Pharmaceutical Co.,Ltd cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.10x
(Capex + Investments) / Operating CF

Total Reinvested

₩2.74 Billion
Capex + Investments

Operating Cash Flow

₩26.51 Billion
KRW

Capital Expenditures

₩1.74 Billion
KRW

Cash Flow Reinvestment Rate of Ilyang Pharmaceutical Co.,Ltd (2014–2025)

Cash flow reinvestment rate of Ilyang Pharmaceutical Co.,Ltd from 2014 to 2025. Historical reinvestment intensity for Ilyang Pharmaceutical Co.,Ltd across 12 annual periods. Explore Ilyang Pharmaceutical Co.,Ltd capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

Ilyang Pharmaceutical Co.,Ltd Cash Flow Reinvestment Rate by Year (2014–2025)

Ilyang Pharmaceutical Co.,Ltd cash flow reinvestment rate by year from 2014 to 2025. Year-by-year capital reinvestment analysis for Ilyang Pharmaceutical Co.,Ltd. For the full cash flow conversion analysis, see Ilyang Pharmaceutical Co.,Ltd (007575) cash flow conversion.

Year Reinvestment Rate Total Reinvested (KRW) Operating CF Capex YoY Change
2025 1.12x ₩13.44 Billion ₩12.04 Billion ₩10.44 Billion ▼ -85.8%
2024 7.83x ₩43.99 Billion ₩5.61 Billion ₩40.62 Billion ▲ +901.3%
2023 0.78x ₩11.44 Billion ₩14.62 Billion ₩6.83 Billion ▼ -27.3%
2022 1.08x ₩32.20 Billion ₩29.94 Billion ₩4.08 Billion ▲ +434.9%
2021 0.20x ₩13.48 Billion ₩67.02 Billion ₩12.91 Billion ▲ +12.3%
2020 0.18x ₩10.29 Billion ₩57.48 Billion ₩10.17 Billion ▼ -25.2%
2019 0.24x ₩8.67 Billion ₩36.19 Billion ₩2.17 Billion ▲ +104.4%
2018 0.12x ₩2.59 Billion ₩22.12 Billion ₩1.55 Billion ▼ -53.7%
2017 0.25x ₩7.60 Billion ₩30.03 Billion ₩3.78 Billion ▼ -67.4%
2016 0.78x ₩20.98 Billion ₩26.98 Billion ₩10.31 Billion ▲ +87.2%
2015 0.42x ₩16.72 Billion ₩40.27 Billion ₩16.07 Billion ▼ -44.4%
2014 0.75x ₩13.92 Billion ₩18.63 Billion ₩13.89 Billion —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow